ci 988 has been researched along with meglumine in 127 studies
Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (meglumine) | Trials (meglumine) | Recent Studies (post-2010) (meglumine) |
---|---|---|---|---|---|
147 | 8 | 14 | 4,168 | 413 | 1,399 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 104 (81.89) | 18.2507 |
2000's | 15 (11.81) | 29.6817 |
2010's | 8 (6.30) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Branchereau, P; Champagnat, J; Denavit-Saubie, M; Roques, BP | 1 |
Field, MJ; Hughes, J; Singh, L; Vass, CA; Woodruff, GN | 1 |
Kearney, AS; Mehta, SC; Radebaugh, GW | 1 |
Spealman, RD | 1 |
Crawley, JN | 1 |
Fincham, CI; Higginbottom, M; Hill, DR; Horwell, DC; O'Toole, JC; Ratcliffe, GS; Rees, DC; Roberts, E | 1 |
Hökfelt, T; Horwell, DC; Hughes, J; Wiesenfeld-Hallin, Z; Xu, XJ | 3 |
Drysdale, MJ; Horwell, DC; Pritchard, MC | 1 |
Costall, B; Domeney, AM; Hughes, J; Kelly, ME; Naylor, RJ; Woodruff, GN | 1 |
Barrett, JE; Powell, KR | 1 |
Hughes, J; Hunter, JC; Woodruff, GN | 1 |
Field, MJ; Hughes, J; Menzies, R; Oles, RJ; Singh, L; Vass, CA; Woodruff, GN | 1 |
Harding, M; Hayward, NJ; Hughes, J; Lloyd, SA; McKnight, AT; Woodruff, GN | 1 |
Campbell, BJ; Dimaline, R; Dockray, GJ; Hughes, J | 1 |
Boden, P; Hill, DR; Hughes, J; Pinnock, R; Singh, L; Woodruff, GN | 1 |
Horwell, DC | 1 |
Boden, P; Costall, B; Domeney, A; Horwell, DC; Hughes, J; Hunter, JC; Kelly, E; Pinnock, RD; Woodruff, GN | 1 |
Field, MJ; Hughes, J; Lewis, AS; Singh, L; Woodruff, GN | 1 |
Chen, D; Ding, XQ; Håkanson, R | 1 |
Gaw, AJ; Hills, DM; Spraggs, CF | 1 |
Birkemo, LS; Croom, DK; Dezube, M; Dougherty, RW; Ervin, GN; Grizzle, MK; James, MK; Johnson, MF; Mosher, JT; Sugg, EE | 1 |
Hoffmann, O; Wiesenfeld-Hallin, Z | 2 |
Bickerdike, MJ; Dourish, CT; Fletcher, A; Marsden, CA | 1 |
Blommaert, A; Fournié-Zaluski, MC; Noble, F; Roques, BP | 1 |
Blommaert, AG; Ducos, B; Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
Corwin, RL; Crawley, JN; Hardy, M; Jörn, A | 1 |
Daum, P; Hill, DR; Pinnock, RD; Suman-Chauhan, N; Woodruff, GN | 1 |
Derrien, M; Ducos, B; Durieux, C; McCort-Tranchepain, I; Roques, BP | 1 |
Dooley, DJ; Klamt, I | 1 |
Blanchard, JC; Böhme, GA; Lemaire, M; Piot, O; Roques, BP | 1 |
Abelson, JL; Bammert-Adams, J; Curtis, GC; Fantone, R; Nesse, R; Pyke, RE | 1 |
Akuzawa, S; Ito, H; Kamato, T; Katuyama, Y; Kobayashi, A; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
Hökfelt, T; Hughes, J; Jing-Xia, H; Seiger, Å; Wiesenfeld-Hallin, Z; Xiao-Jun, X | 1 |
Black, JW; Shankley, NP; Welsh, NJ | 1 |
Dickinson, CJ; Seva, C; Yamada, T | 1 |
Massey, BW; Vanover, KE; Woolverton, WL | 1 |
Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 2 |
Higginbottom, M; Hill, DR; Horwell, DC; Mostafai, E; Roberts, E; Suman-Chauhan, N | 1 |
Chiba, T; DelValle, J; Park, J; Yamada, T | 1 |
Campbell, BJ; Dimaline, R; Dockray, GJ; Garner, A; Hughes, J | 1 |
Blackmore, M; Doherty, E; Hirst, BH; Manning, JE | 1 |
Dickenson, A; Stanfa, L; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Blommaert, A; Derrien, M; Durieux, C; Fournié-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
Chapman, KL; Freedman, SB; Heald, A; Patel, S; Smith, AJ | 2 |
Hökfelt, T; Hughes, J; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Ohtsuka, T; Yokose, K | 1 |
Boyle, SJ; McKnight, AT; Tang, KW; Woodruff, GN | 1 |
Christoffersen, CL; Meltzer, LT; Razmpour, A; Serpa, KA | 1 |
Dimaline, R; Dockray, GJ; Evans, D; Forster, ER; Sandvik, AK | 1 |
Hökfelt, T; Hughes, J; Puke, MJ; Verge, VM; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Blommaert, AG; Fournié-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
Hinks, GL; Hughes, J; Poat, JA | 1 |
Bradwejn, J; Hinton, J; Koszycki, D; Paradis, M; Reece, P; Sedman, A | 1 |
Rakovska, A | 1 |
Brotchi, J; Camby, I; Danguy, A; Kiss, R; Martinez, J; Pasteels, JL; Salmon, I | 1 |
Howes, LG; Morris, DL; Romani, R | 2 |
Boyce, S; Rupniak, NM; Webb, JK | 1 |
Goudreau, N; Guillaume-Rousselet, N; Jagerschmidt, A; Maigret, B; Roques, BP; Vikland, ML | 1 |
Bado, A; Blommaert, AG; Böhme, A; Ducos, B; Garbay, C; Moizo, L; Roques, BP; Weng, JH | 1 |
Birkemo, LS; Ervin, GN; Johnson, MF; Mosher, JT | 1 |
Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG | 1 |
Champagnat, J; Denavit-Saubie, M; McLean, HA | 1 |
Araldi, G; Donati, D; Natalini, B; Oliosi, B; Pellicciari, R; Tarzia, G; Ursini, A; van Amsterdam, F | 1 |
Bjorge, SM; Hinton, JP; Hoffman, K; Jennings, K; Pablo, JC; Wright, DS | 1 |
Atwal, P; Field, MJ; Hunter, JC; Oles, RJ; Singh, L; Woodruff, GN | 1 |
Horwell, D; Pritchard, M; Raphy, J; Ratcliffe, G | 1 |
Fournié-Zaluski, MC; Maldonado, R; Roques, BP; Ruiz, F | 1 |
Dockray, GJ; Forster, E; Garcia, L; Hill, D; Horwell, DC; Hughes, J; Pritchard, MC; Toescu, E; Woodruff, G | 1 |
Adams, JB; Cook, J; Cowley, DS; Pyke, RE; Roy-Byrne, PP; Wingerson, D; Zaccharias, P | 1 |
Brown, P; Field, M; Hinks, GL; Hughes, J; Poat, JA | 1 |
Augelli-Szafran, CE; Hill, D; Horwell, DC; Kneen, C; Ortwine, DF; Pritchard, MC; Purchase, TS; Roth, BD; Suman-Chauhan, N; Trivedi, BK; Webdale, L | 1 |
Durieux, C; Léna, I; Roques, BP | 1 |
Jenck, F; Martin, JR; Moreau, JL | 1 |
den Boer, JA; Pande, AC; Slaap, B; van Es-Radhakishun, F; van Megen, HJ; Westenberg, HG | 1 |
Ahmed, M; Ballinger, A; Clark, M; Kumar, P | 1 |
Besson, JM; Buritova, J; Fournié-Zaluski, MC; Honore, P; Roques, BP | 1 |
Endo, T; Nagasaki, M; Noto, T | 1 |
Maldonado, R; Roques, BP; Smadja, C; Valverde, O | 1 |
Marvik, R; Sandvik, AK; Waldum, HL | 1 |
Elfvin, A; Fournié-Zaluski, MC; Hao, JX; Roques, BP; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Coric, P; Fournié-Zaluski, MC; Maldonado, R; Roques, BP; Ruiz, F; Smadja, C | 1 |
Costall, B; Naylor, RJ | 1 |
Bestervelt, LL; Dethloff, LA; Patmore, SJ; Tierney, BM; Zandee, JC | 1 |
Lucas, GA; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Roques, BP; Valverde, O | 1 |
Little, HJ; Wilson, J | 1 |
Alster, P; Brodin, E; de Araújo Lucas, G; Gustafsson, H; Schött, E; Stiller, CO; Wiesenfeld-Hallin, Z | 1 |
Little, HJ; Watson, WP; Wilson, J | 1 |
Alchepo, B; Attoub, S; Bado, A; Laigneau, JP; Lewin, MJ; Moizo, L | 1 |
Hinton, JP; Trivedi, BK | 1 |
Aldskogius, H; Grant, G; Hao, JX; Hökfelt, T; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
de Tullio, P; Delarge, J; Pirotte, B | 1 |
Black, JW; Griffin, EP; Harper, EA; Shankley, NP | 1 |
Black, JW; Harper, EA; Shankley, NP | 1 |
Charney, DS; Goddard, AW; Goodman, WK; Heninger, GR; Money, R; Pande, AC; Price, LH; Woods, SW | 1 |
Dickinson, CJ; Sawada, M; Stepan, VM; Todisco, A | 1 |
Akil, H; Day, HE | 1 |
Adams, JB; Greiner, M; Lydiard, RB; Pande, AC; Pierce, MW | 1 |
Broberger, C; Farkas-Szallasi, T; Hökfelt, T; Lundberg, JM; Szallasi, A; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
Barr, B; Bestervelt, L; Dethloff, L | 1 |
Pache, DM; Sewell, RD; Subhan, F | 1 |
Ardid, D; Boucher, M; Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Méen, M | 1 |
Bradley, EL; Bright, CA; Kissin, I | 1 |
Fournié-Zaluski, M; Hutcheson, DM; Maldonado, R; Pache, DM; Roques, BP; Sewell, RD; Subhan, F | 1 |
Boucher, M; Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J | 1 |
Kamei, J; Zushida, K | 1 |
Antonelli, T; Bebe, BW; Ferraro, L; Glennon, J; O'Connor, WT; Tanganelli, S; Tomasini, MC | 1 |
Kamei, J; Nagase, H; Zushida, K | 1 |
Boucher, M; Coudoré-Civiale, MA; Eschalier, A; Fournié-Zaluski, MC; Méen, M; Roques, BP | 1 |
Jensen, RT; Moody, TW | 1 |
Lawrence, AJ; Lodge, DJ | 1 |
Canestrelli, C; Chen, H; Cupo, A; Fournié-Zaluski, MC; Le Guen, S; Maldonado, R; Mas Nieto, M; Noble, F; Roques, BP | 1 |
Cho, HY; Hong, SK; Kim, J; Kim, JH; Kim, Y; Yoon, YW | 1 |
Becker, C; Benoliel, JJ; Blugeot, A; Mauborgne, A; Pohl, M; Rivat, C; Zeau, B | 1 |
Benturquia, N; Canestrelli, C; Crete, D; Mas Nieto, M; Noble, F; Roques, BP; Wilson, J | 1 |
Akiyama, M; Goto, Y; Inagaki, M; Izumi, H; Kaga, M; Li, H; Matsuda, Y; Matsushima, Y; Ohta, H; Seki, M; Toda, T | 1 |
Frommelt, L; Goebel-Stengel, M; Hofmann, T; Klapp, BF; Kobelt, P; Lembke, V; Mönnikes, H; Stengel, A; Wiedenmann, B | 1 |
Asico, LD; Chen, Y; He, D; Jose, PA; Villar, VA; Zeng, C; Zheng, S; Zhou, L | 1 |
Bagot, RC; Berton, O; Cahill, ME; Dietz, DM; Fallon, B; Feng, J; Ferguson, D; Harrigan, E; Joshi, T; Ku, SM; Mazei-Robison, M; Nestler, EJ; Robison, AJ; Vialou, V; Winstanley, CA | 1 |
Jensen, RT; Moody, TW; Moreno, P; Nuche-Berenguer, B | 1 |
Kaczyńska, K; Szereda-Przestaszewska, M | 1 |
7 review(s) available for ci 988 and meglumine
Article | Year |
---|---|
Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Cholecystokinin; gamma-Aminobutyric Acid; Indoles; Meglumine; Receptors, Cholecystokinin; Spinal Cord; Substance-Related Disorders | 1991 |
Functional role of brain CCK receptors.
Topics: Animals; Autoradiography; Benzodiazepinones; Binding Sites; Brain; Devazepide; Indoles; Meglumine; Mice; Rats; Receptors, Cholecystokinin; Sincalide | 1991 |
Cholecystokinin and morphine analgesia: variations on a theme.
Topics: Analgesia; Animals; Benzodiazepinones; Cholecystokinin; Humans; Indoles; Meglumine; Morphine; Phenylurea Compounds; Receptors, Cholecystokinin | 1994 |
[Cholecystokinin receptor antagonists].
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Furans; Indoles; Meglumine; Molecular Sequence Data; Proglumide; Receptors, Cholecystokinin; Sincalide; Thiophenes | 1993 |
'Targeted' molecular diversity: design and development of non-peptide antagonists for cholecystokinin and tachykinin receptors.
Topics: Amino Acid Sequence; Animals; Drug Design; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Ligands; Meglumine; Molecular Structure; Oligopeptides; Peptide Library; Phenylalanine; Receptors, Cholecystokinin; Receptors, Tachykinin; Tryptophan | 1996 |
CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile.
Topics: Adamantane; Administration, Oral; Animals; Brain; Humans; Indoles; Meglumine; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship; Tryptophan | 1998 |
Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Humans; Indoles; Keto Acids; Ligands; Meglumine; Peptoids; Proglumide; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spiro Compounds; Structure-Activity Relationship; Tetragastrin | 1999 |
7 trial(s) available for ci 988 and meglumine
Article | Year |
---|---|
The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolam.
Topics: Adult; Alprazolam; Cross-Over Studies; Double-Blind Method; Humans; Hypothalamo-Hypophyseal System; Indoles; Meglumine; Middle Aged; Pituitary-Adrenal System; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1995 |
Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
Topics: Adult; Amino Acid Sequence; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Hemodynamics; Humans; Indoles; Male; Meglumine; Middle Aged; Molecular Sequence Data; Panic; Psychiatric Status Rating Scales; Receptors, Cholecystokinin; Tetragastrin | 1995 |
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome | 1995 |
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panic.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Heart Rate; Humans; Indoles; Lactic Acid; Male; Meglumine; Panic Disorder; Psychiatric Status Rating Scales; Receptors, Cholecystokinin | 1996 |
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrocortisone; Indoles; Male; Meglumine; Middle Aged; Panic Disorder; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetragastrin; Treatment Outcome | 1997 |
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder.
Topics: Adult; Affect; Analysis of Variance; Anti-Anxiety Agents; Anxiety Disorders; Blood Pressure; Female; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Indoles; Male; Meglumine; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Serotonin Receptor Agonists | 1999 |
Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Meglumine; Middle Aged; Panic Disorder; Receptors, Cholecystokinin | 1999 |
113 other study(ies) available for ci 988 and meglumine
Article | Year |
---|---|
CCK modulates inhibitory synaptic transmission in the solitary complex through CCKB sites.
Topics: Animals; Benzodiazepinones; Bicuculline; Brain Stem; Cholecystokinin; Devazepide; gamma-Aminobutyric Acid; Immunohistochemistry; In Vitro Techniques; Indoles; Interneurons; Medulla Oblongata; Meglumine; Membrane Potentials; Microelectrodes; Phenylurea Compounds; Rats; Receptors, Cholecystokinin; Synapses; Synaptic Transmission; Vagus Nerve | 1992 |
The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Diazepam; Drug Administration Schedule; Indoles; Light; Male; Meglumine; Mice; Mice, Inbred Strains; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1992 |
Aqueous stability and solubility of CI-988, a novel "dipeptoid" cholecystokinin-B receptor antagonist.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Hydrolysis; Indoles; Meglumine; Receptors, Cholecystokinin; Solubility | 1992 |
Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Cocaine; Devazepide; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Indoles; Male; Meglumine; Receptors, Cholecystokinin; Reinforcement Schedule; Saimiri | 1992 |
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Topics: Animals; Behavior, Animal; Benzodiazepinones; Cholecystokinin; Darkness; Devazepide; Dopamine; Indoles; Injections, Intraperitoneal; Limbic System; Male; Meglumine; Microinjections; Motor Activity; Nucleus Accumbens; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Tegmentum Mesencephali | 1992 |
Amide bond replacements incorporated into CCK-B selective "dipeptoids".
Topics: Amides; Cholecystokinin; Indoles; Meglumine; Models, Molecular; Receptors, Cholecystokinin; Structure-Activity Relationship | 1992 |
CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.
Topics: Animals; Behavior, Animal; Drug Tolerance; Indoles; Injections, Intraperitoneal; Male; Meglumine; Morphine; Morphine Dependence; Naloxone; Pain Measurement; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1992 |
Rationally designed "dipeptoid" analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988.
Topics: Animals; Carboxylic Acids; Cholecystokinin; Dipeptides; Drug Design; Indoles; Male; Meglumine; Mice; Rats; Receptors, Cholecystokinin | 1992 |
Anxiolytic effects of CCK-B antagonists.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Callitrichinae; Diazepam; Indoles; Meglumine; Mice; Rats; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1991 |
Evaluation of the effects of PD 134308 (CI-988), a CCK-B antagonist, on the punished responding of squirrel monkeys.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Chlordiazepoxide; Electroshock; Indoles; Male; Meglumine; Punishment; Receptors, Cholecystokinin; Saimiri | 1991 |
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepinones; Carbolines; Central Nervous System Depressants; Cholecystokinin; Conflict, Psychological; Devazepide; Drug Interactions; Ethanol; Hypnotics and Sedatives; Indoles; Injections, Intraventricular; Male; Meglumine; Mice; Motor Activity; Pentagastrin; Pentobarbital; Pentylenetetrazole; Phenylurea Compounds; Postural Balance; Rats; Receptors, Cholecystokinin; Social Behavior | 1991 |
The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Topics: Animals; Anti-Anxiety Agents; Atropine; Benzodiazepinones; Bethanechol Compounds; Cholecystokinin; Dose-Response Relationship, Drug; Gastric Acid; Gastrins; Histamine; Indoles; Male; Meglumine; Omeprazole; Phenylurea Compounds; Ranitidine; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin | 1991 |
PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.
Topics: Analgesics; Animals; Cholecystokinin; Drug Synergism; Female; Galanin; Indoles; Injections, Spinal; Kinetics; Male; Meglumine; Morphine; Naloxone; Nociceptors; Pain; Peptides; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reflex; Sorbitol; Spinal Cord; Time Factors | 1990 |
Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galanin.
Topics: Analgesics; Animals; Drug Interactions; Female; Galanin; Indoles; Injections, Intravenous; Injections, Spinal; Male; Meglumine; Morphine; Naloxone; Pain; Peptides; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reflex; Spinal Cord | 1991 |
Inhibition of food intake by omeprazole in the chicken.
Topics: Animals; Animals, Newborn; Body Weight; Chickens; Depression, Chemical; Eating; Gastrins; Indoles; Meglumine; Omeprazole; Radioimmunoassay; Receptors, Cholecystokinin; Satiety Response | 1991 |
Development of CCK-B antagonists.
Topics: Amino Acid Sequence; Animals; Binding Sites; Blood-Brain Barrier; Cerebral Cortex; Cholecystokinin; Drug Design; Indoles; Meglumine; Mice; Molecular Sequence Data; Peptide Fragments; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship | 1991 |
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Callitrichinae; Cell Membrane; Cerebral Cortex; Cholecystokinin; Electrophysiology; Humans; Indoles; Kinetics; Meglumine; Mice; Pancreas; Rats; Receptors, Cholecystokinin; Social Behavior; Sorbitol; Ventromedial Hypothalamic Nucleus | 1990 |
Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Topics: Animals; Anxiety; Benzodiazepinones; Cerebral Ventricles; Ceruletide; Chlordiazepoxide; Cholecystokinin; Devazepide; Indoles; Injections, Intraventricular; Male; Meglumine; Pentagastrin; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin | 1991 |
Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Topics: Animals; Benzodiazepinones; Devazepide; Enzyme Activation; Gastrins; Histidine Decarboxylase; Indoles; Ligands; Male; Meglumine; Phenethylamines; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Stomach | 1995 |
Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat.
Topics: Adrenalectomy; Adrenergic Agents; Animals; Benzodiazepinones; Blood Pressure; Bradycardia; Cholecystokinin; Decerebrate State; Devazepide; Dose-Response Relationship, Drug; Gastrins; Guanethidine; Heart Rate; Hormone Antagonists; Hormones; Hypertension; Indoles; Male; Meglumine; Pentagastrin; Phentolamine; Proglumide; Rats; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1995 |
Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
Topics: Adamantane; Amino Acid Sequence; Animals; Appetite Depressants; CHO Cells; Cricetinae; Humans; Indoles; Ligands; Magnetic Resonance Spectroscopy; Male; Meglumine; Molecular Sequence Data; Peptoids; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spectrometry, Mass, Fast Atom Bombardment; Tetragastrin; Tryptophan | 1995 |
The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Indoles; Male; Meglumine; Morphine; Nociceptors; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Cholecystokinin; Time Factors | 1994 |
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Devazepide; Diazepam; Indoles; Male; Maze Learning; Meglumine; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Rats; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors; Zimeldine | 1994 |
A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Topics: Analgesics; Animals; Disulfides; Enkephalins; Formaldehyde; Indoles; Male; Meglumine; Mice; Morphine; Naloxone; Naltrexone; Pain Measurement; Phenylalanine; Receptors, Cholecystokinin; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
Topics: Analgesics; Animals; Behavior, Animal; Binding, Competitive; Body Temperature; Diprenorphine; Disulfides; Drug Combinations; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Mice; Morphine; Motor Activity; Naloxone; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Weight Loss | 1995 |
The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism.
Topics: Animals; Calcium; Cholecystokinin; Dopamine; Dopamine Antagonists; Indoles; Male; Meglumine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Tetrodotoxin | 1995 |
The cholecystokinin-induced increase in intracellular calcium in AR42J cells is mediated by CCKB receptors linked to internal calcium stores.
Topics: Animals; Benzodiazepinones; Bridged-Ring Compounds; Calcium; Cholecystokinin; Devazepide; Dipeptides; Gastric Mucosa; Guinea Pigs; Indoles; Manganese; Meglumine; Pentagastrin; Rats; Receptors, Cholecystokinin; Tumor Cells, Cultured | 1994 |
Heterogeneity of CCK-B receptors involved in animal models of anxiety.
Topics: Amino Acid Sequence; Animals; Anxiety; Behavior, Animal; Benzodiazepinones; Cholecystokinin; Devazepide; Guinea Pigs; In Vitro Techniques; Indoles; Male; Meglumine; Mice; Molecular Sequence Data; Pancreas; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cholecystokinin | 1994 |
Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Electroshock; Exploratory Behavior; Flumazenil; Indoles; Male; Meglumine; Mice; Ondansetron; Receptors, Cholecystokinin | 1993 |
CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Cognition; Indoles; Male; Meglumine; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Smell; Social Behavior | 1994 |
Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Mucosa; Histamine; In Vitro Techniques; Indoles; Male; Meglumine; Pentagastrin; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide | 1994 |
Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Cholecystokinin; Chronic Disease; Diazepam; Endorphins; Female; Indoles; Meglumine; Naloxone; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Spinal Cord Injuries; Vocalization, Animal | 1994 |
Comparative analysis of the vagal stimulation of gastric acid secretion in rodent isolated stomach preparations.
Topics: Animals; Atropine; Cholecystokinin; Cholinergic Antagonists; Electric Stimulation; Gastric Acid; Gastric Mucosa; Guinea Pigs; Hexamethonium Compounds; Histamine H2 Antagonists; Hydrogen-Ion Concentration; In Vitro Techniques; Indoles; Male; Meglumine; Mice; Rats; Rats, Wistar; Receptors, Cholecystokinin; Species Specificity; Tetrodotoxin; Vagus Nerve | 1994 |
Growth-promoting effects of glycine-extended progastrin.
Topics: Benzodiazepinones; Binding Sites; Cell Division; Gastrins; Humans; Indoles; Meglumine; Octreotide; Ornithine Decarboxylase; Phenylurea Compounds; Receptors, Cholecystokinin; Tumor Cells, Cultured | 1994 |
Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Cocaine; Devazepide; Discrimination Learning; Dopamine; Dose-Response Relationship, Drug; Female; Indoles; Macaca mulatta; Male; Meglumine; Mesencephalon; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Receptors, Dopamine; Substance-Related Disorders; Synaptic Transmission | 1994 |
Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Topics: Adamantane; Analgesics; Animals; Benzodiazepinones; Dipeptides; Disulfides; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Nociceptors; Pain Measurement; Phenylalanine; Phenylurea Compounds; Prodrugs; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Regression Analysis; Tail | 1994 |
Conformationally restricted analogues of the potent CCK-B antagonist CI-988.
Topics: Animals; Binding Sites; Cerebral Cortex; In Vitro Techniques; Indoles; Kinetics; Magnetic Resonance Spectroscopy; Meglumine; Mice; Molecular Conformation; Molecular Structure; Pancreas; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stereoisomerism; Structure-Activity Relationship | 1993 |
Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
Topics: Animals; Benzodiazepinones; Binding, Competitive; Cells, Cultured; Cholecystokinin; Devazepide; Dogs; Gastric Fundus; Gastric Mucosa; Gastrins; Indoles; Kinetics; Meglumine; Receptors, Cholecystokinin; Sincalide; Somatostatin | 1993 |
The mechanism of action of gastrin releasing peptide (GRP) in stimulating avian gastric acid secretion.
Topics: Analysis of Variance; Animals; Bombesin; Chickens; Dose-Response Relationship, Drug; Gastric Acid; Gastrin-Releasing Peptide; Gastrins; Indoles; Male; Meglumine; Oligopeptides; Peptides; Receptors, Cholecystokinin; Turkeys | 1994 |
Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
Topics: Benzamides; Benzodiazepinones; Cell Division; Devazepide; Gastrins; Humans; Indoles; Kidney Neoplasms; Meglumine; Phenylurea Compounds; Proglumide; Receptors, Cholecystokinin; Tumor Cells, Cultured; Wilms Tumor | 1994 |
CCK-B antagonists exhibit antidepressant-like effects and potentiate endogenous enkephalin analgesia. Correlation with in vivo binding affinities and brain penetration.
Topics: Animals; Antidepressive Agents; Benzodiazepinones; Blood-Brain Barrier; Brain; Cerebral Ventricles; Cholecystokinin; Electroshock; Indoles; Injections, Intraventricular; Meglumine; Mice; Motor Activity; Peptide Fragments; Phenylurea Compounds; Receptors, Cholecystokinin | 1994 |
Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Brain; Cerebral Ventricles; Indoles; Injections, Intraventricular; Inulin; Iodine Radioisotopes; Male; Meglumine; Mice; Mice, Inbred Strains; Phenylurea Compounds; Radioligand Assay; Receptors, Cholecystokinin; Tetrazoles | 1994 |
The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.
Topics: Animals; Axons; Depression, Chemical; Drug Synergism; Electromyography; Female; Indoles; Meglumine; Morphine; Nociceptors; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Reflex; Sciatic Nerve | 1994 |
Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding.
Topics: Analysis of Variance; Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Brain; Guinea Pigs; Indoles; Injections, Intravenous; Injections, Intraventricular; Male; Meglumine; Mice; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Succinimides; Tetrazoles | 1994 |
Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Topics: Animals; Benzodiazepinones; Carbachol; Cholecystokinin; Devazepide; Gastric Mucosa; Gastrins; Guinea Pigs; In Vitro Techniques; Indoles; Male; Meglumine; Muscle Contraction; Muscle, Smooth; Phenylurea Compounds; Receptors, Cholecystokinin; Stomach | 1993 |
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
Topics: Animals; Apomorphine; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Indoles; Male; Meglumine; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substantia Nigra; Tegmentum Mesencephali | 1993 |
Control of gastric corpus chromogranin A messenger RNA abundance in the rat.
Topics: Animals; Base Sequence; Blotting, Northern; Chromogranin A; Chromogranins; Fasting; Female; Gastric Mucosa; Gastrins; Indoles; Meglumine; Molecular Sequence Data; Omeprazole; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; RNA, Messenger; Stomach | 1993 |
Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.
Topics: Animals; Cholecystokinin; Ganglia, Spinal; Indoles; Male; Meglumine; Morphine; Neurons, Afferent; Pain; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; RNA, Messenger; Sciatic Nerve; Self Mutilation | 1993 |
Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
Topics: Analgesics; Animals; Benzodiazepinones; Disulfides; Drug Synergism; Drug Tolerance; Indoles; Male; Meglumine; Mice; Pain Measurement; Phenylalanine; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Time Factors | 1995 |
Changes in hypothalamic cholecystokininA and cholecystokininB receptor subtypes and associated neuropeptide expression in response to salt-stress in the rat and mouse.
Topics: Animals; Autoradiography; Benzodiazepinones; Cholecystokinin; Devazepide; Hormone Antagonists; Hypothalamus; In Situ Hybridization; Indoles; Male; Meglumine; Mice; Mice, Inbred Strains; Neuronal Plasticity; Neuropeptides; Oligonucleotide Probes; Osmolar Concentration; Rats; Rats, Wistar; Receptors, Cholecystokinin; RNA, Messenger; Saline Solution, Hypertonic; Succinimides | 1995 |
Cholecystokinin-GABA interactions in rat striatum.
Topics: Animals; Calcium; Cholecystokinin; Corpus Striatum; Electric Stimulation; gamma-Aminobutyric Acid; Hormone Antagonists; Indoles; Male; Meglumine; Proglumide; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Tetrodotoxin; Tritium | 1995 |
Influence of gastrin on human astrocytic tumor cell proliferation.
Topics: Amino Acid Sequence; Astrocytoma; Autoradiography; Benzodiazepinones; Brain Neoplasms; Cell Division; Cholecystokinin; Devazepide; Gastrins; Hormone Antagonists; Humans; Indoles; Meglumine; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Receptors, Cholecystokinin; Sincalide; Thymidine; Tritium; Tumor Cells, Cultured | 1996 |
Gastrin receptor antagonist CI-988 inhibits growth of human colon cancer in vivo and in vitro.
Topics: Administration, Oral; Analysis of Variance; Animals; Cell Division; Colorectal Neoplasms; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Receptors, Cholecystokinin; Tumor Cells, Cultured | 1996 |
Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide.
Topics: Animals; Blood Pressure; Carbolines; Chlordiazepoxide; Hormone Antagonists; Indoles; Male; Meglumine; Pentagastrin; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1996 |
Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist, CI-988.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Division; Colorectal Neoplasms; Dose-Response Relationship, Drug; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Cholecystokinin; Tumor Cells, Cultured | 1996 |
His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
Topics: Animals; Arginine; Base Sequence; Benzodiazepinones; Cholecystokinin; Devazepide; Histidine; Indoles; Meglumine; Models, Molecular; Molecular Sequence Data; Phenylurea Compounds; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1996 |
Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats.
Topics: Analgesics, Opioid; Animals; Antitussive Agents; Dextromethorphan; Drug Synergism; Drug Tolerance; Hormone Antagonists; Indoles; Male; Meglumine; Morphine; Pain Measurement; Rats; Rats, Sprague-Dawley | 1996 |
Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Benzodiazepinones; CHO Cells; Cholecystokinin; Cricetinae; Dose-Response Relationship, Drug; Electrophysiology; Gastric Acid; Gastrointestinal Agents; Hippocampus; Indoles; Inositol Phosphates; Male; Meglumine; Molecular Sequence Data; Neurons; Neurotransmitter Agents; Oligopeptides; Pentagastrin; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship; Time Factors; Transfection | 1996 |
Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Topics: Animals; Benzodiazepinones; Chlordiazepoxide; Conditioning, Psychological; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Indoles; Lithium Chloride; Male; Meglumine; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Taste | 1996 |
The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.
Topics: Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Enkephalins; Hormone Antagonists; Indoles; Male; Meglumine; Morphine; Pain Measurement; Rats; Rats, Wistar; Receptors, Cholecystokinin | 1996 |
A cholecystokinin-B receptor antagonist potentiates GABAergic and glycinergic inhibition in the nucleus of the solitary tract of the rat.
Topics: Animals; Anti-Anxiety Agents; Chloride Channel Agonists; Drug Synergism; Electric Conductivity; Evoked Potentials; gamma-Aminobutyric Acid; Glycine; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Meglumine; Neural Inhibition; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Solitary Nucleus; Tetrodotoxin | 1996 |
Synthesis and receptor binding affinity of cholecystokinin receptor ligands: 2-and 1-indolyl derivatives of PD134308.
Topics: Animals; Binding, Competitive; Brain Chemistry; Guinea Pigs; Hormone Antagonists; Hydrolysis; In Vitro Techniques; Indoles; Ligands; Male; Meglumine; Receptors, Cholecystokinin; Spectrophotometry, Infrared | 1996 |
Three complementary liquid chromatographic methods for determination of the peptoid cholecystokinin-B antagonist, CI-988, in rat plasma.
Topics: Animals; Anions; Cholecystokinin; Chromatography, High Pressure Liquid; Hormone Antagonists; Indoles; Mass Spectrometry; Meglumine; Peptoids; Rats; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence | 1996 |
Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hormone Antagonists; Indoles; Male; Meglumine; Morphine; Pain Threshold; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cholecystokinin | 1996 |
Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.
Topics: Analgesics; Animals; Disulfides; Drug Combinations; Enkephalins; Indoles; Male; Meglumine; Methadone; Morphine; Naloxone; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1996 |
Characterization of novel peptoid agonists for the CCK-A receptor.
Topics: Adamantane; Amylases; Animals; Calcium; Dose-Response Relationship, Drug; Hormone Antagonists; Indoles; Meglumine; Mice; Pancreas; Peptoids; Phenethylamines; Rats; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 1996 |
The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Chlordiazepoxide; Gene Expression Regulation; Genes, Immediate-Early; Indoles; Male; Meglumine; Rats; RNA, Messenger; Transcriptional Activation | 1996 |
Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988.
Topics: Animals; Hormone Antagonists; Indoles; Meglumine; Mice; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship | 1996 |
Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
Topics: Animals; Benzodiazepinones; Binding Sites; Calcium; Cholecystokinin; Culture Media; Devazepide; Dopamine; Hormone Antagonists; Indoles; Male; Meglumine; Nucleus Accumbens; Peptide Fragments; Potassium; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetrodotoxin | 1997 |
Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Caffeine; Clonazepam; Dose-Response Relationship, Drug; Indoles; Male; Meglumine; Phenylurea Compounds; Rats; Rats, Wistar | 1996 |
Gastrin effects on growth and exocrine secretion in the neonatal rat pancreas.
Topics: Amylases; Animals; Animals, Newborn; Female; Gastrins; Hormone Antagonists; In Vitro Techniques; Indoles; Male; Meglumine; Pancreas; Pregnancy; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide | 1997 |
Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Topics: Analgesics; Animals; Benzodiazepinones; Devazepide; Disulfides; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Indoles; Male; Meglumine; Pain; Phenylalanine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spinal Cord | 1997 |
Role of vagus nerves and gastrin in the gastric phase of acid secretion in male anesthetized rats.
Topics: Animals; Deoxyglucose; Gastric Acid; Gastric Mucosa; Gastrins; Hormone Antagonists; Indoles; Male; Meglumine; Peptones; Physical Stimulation; Rats; Rats, Wistar; Stomach; Vagotomy; Vagus Nerve | 1997 |
The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist.
Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Indoles; Male; Meglumine; Morphine; Rats; Receptors, Cholecystokinin; Stress, Physiological; Time Factors | 1997 |
Evaluation of biologic gastrin activity of compound CI-988 in the isolated, vascularly perfused rat stomach.
Topics: Animals; Gastric Acid; Gastrins; Histamine Release; Hormone Antagonists; Indoles; Male; Meglumine; Peptoids; Perfusion; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stomach | 1997 |
CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level.
Topics: Analgesics; Animals; Decerebrate State; Disulfides; Dose-Response Relationship, Drug; Drug Synergism; Female; Hormone Antagonists; Indoles; Injections, Intravenous; Meglumine; Nociceptors; Opioid Peptides; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex; Spinal Cord | 1997 |
CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.
Topics: Amygdala; Animals; Caudate Nucleus; Disulfides; Enkephalins; Enzyme Inhibitors; Hormone Antagonists; Indoles; Injections, Intraventricular; Limbic System; Male; Meglumine; Mice; Motor Activity; Neprilysin; Nucleus Accumbens; Phenylalanine; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1997 |
The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Topics: Animals; Avoidance Learning; Behavior, Animal; Benzodiazepinones; Darkness; Devazepide; Diazepam; Drug Antagonism; Fenclonine; Indoles; Light; Losartan; Male; Meglumine; Mice; Organophosphorus Compounds; Proline; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Ritanserin; Serotonin Antagonists; Sulfonamides | 1997 |
Gastric effects of the CCK-B/gastrin receptor ligand CI-988 in cynomolgus monkeys.
Topics: Animals; Benzodiazepinones; Gastric Acid; Gastric Mucosa; Indoles; Ligands; Macaca fascicularis; Meglumine; Phenylurea Compounds; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1998 |
On the role of cholecystokinin in the mediation of spinal reflex excitability in intact and axotomized rats.
Topics: Animals; Axotomy; Cholecystokinin; Electric Stimulation; Female; Indoles; Injections, Spinal; Meglumine; Nerve Fibers; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex; Sciatic Nerve | 1998 |
Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Benzodiazepinones; Cholecystokinin; Conditioning, Classical; Devazepide; Indoles; Male; Meglumine; Morphine Dependence; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1998 |
CCK(B) antagonists protect against some aspects of the ethanol withdrawal syndrome.
Topics: Acoustic Stimulation; Alcoholism; Animals; Anti-Anxiety Agents; Behavior, Animal; Central Nervous System Depressants; Dipeptides; Ethanol; Excitatory Amino Acid Agonists; Handling, Psychological; Indoles; Male; Meglumine; Mice; Mice, Inbred Strains; N-Methylaspartate; Receptors, Cholecystokinin; Seizures; Substance Withdrawal Syndrome | 1998 |
Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors.
Topics: Animals; Anti-Anxiety Agents; Axotomy; Cholecystokinin; Indoles; Male; Meglumine; Microdialysis; Potassium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sciatic Nerve; Spinal Cord | 1998 |
CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze.
Topics: Animals; Anxiety; Dipeptides; Ethanol; Indoles; Male; Maze Learning; Meglumine; Mice; Motor Activity; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Serotonin; Substance Withdrawal Syndrome | 1998 |
YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
Topics: Aminopyrine; Animals; Benzodiazepines; Benzodiazepinones; Cats; Cholecystokinin; Dose-Response Relationship, Drug; Gastric Acid; Gastric Fistula; Gastric Mucosa; Gastrins; Hormone Antagonists; Indoles; Male; Meglumine; Phenylurea Compounds; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1998 |
Central inhibitory dysfunctions: mechanisms and clinical implications.
Topics: Animals; Baclofen; Central Nervous System; Cholecystokinin; GABA Agonists; Hormone Antagonists; Indoles; Ischemia; Meglumine; Narcotics; Neural Inhibition; Pain; Pain Measurement; Peripheral Nervous System; Rats; Receptors, GABA; Spinal Cord; Spinal Cord Injuries | 1997 |
Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Binding, Competitive; Bridged-Ring Compounds; Cerebral Cortex; Dipeptides; Guinea Pigs; Hormone Antagonists; Indoleacetic Acids; Indoles; Iodine Radioisotopes; Male; Meglumine; Mice; Pancreas; Phenylurea Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Succinimides; Thiazoles; Tritium | 1999 |
Characterization of the binding of a novel radioligand to CCKB/gastrin receptors in membranes from rat cerebral cortex.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Binding, Competitive; Bridged-Ring Compounds; Cerebral Cortex; Dipeptides; Dose-Response Relationship, Drug; Hormone Antagonists; Indoles; Kinetics; Male; Meglumine; Membranes; Nootropic Agents; Pentagastrin; Phenylurea Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tritium | 1999 |
Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.
Topics: Animals; Antineoplastic Agents; Binding Sites; Binding, Competitive; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Colonic Neoplasms; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; ets-Domain Protein Elk-1; Flavonoids; Gastrins; Gene Expression Regulation; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Meglumine; Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Rats; Receptors, Cholecystokinin; Recombinant Proteins; Response Elements; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Cells, Cultured | 1999 |
Evidence that cholecystokinin receptors are not involved in the hypothalamic-pituitary-adrenal response to intraperitoneal administration of interleukin-1beta.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Area Under Curve; Corticosterone; Devazepide; Hypothalamo-Hypophyseal System; Indoles; Injections, Intraperitoneal; Interleukin-1; Male; Meglumine; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Recombinant Proteins | 1999 |
Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
Topics: Animals; Cholecystokinin; Decerebrate State; Diterpenes; Ganglia, Spinal; Hormone Antagonists; Indoles; Injections, Subcutaneous; Male; Meglumine; Morphine; Neurons; Neurotoxins; Pain; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex; RNA, Messenger; Spinal Cord; Time Factors; Transcription, Genetic | 2000 |
Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells.
Topics: Animals; Antineoplastic Agents; Cell Division; Gastrins; Hormone Antagonists; Indoles; Ligands; Meglumine; Pancreatic Neoplasms; Rats; Receptors, Cholecystokinin; Signal Transduction; Tumor Cells, Cultured | 2000 |
Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine.
Topics: Alanine; Animals; Conditioning, Operant; Disulfides; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Indoles; Male; Meglumine; Narcotics; Protease Inhibitors; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors | 2000 |
Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Male; Meglumine; Morphine; Nociceptors; Pain; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors | 2000 |
Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems.
Topics: Alfentanil; Analgesia; Analgesics, Opioid; Animals; Benzodiazepinones; Cholecystokinin; Dizocilpine Maleate; Drug Tolerance; Indoles; Infusions, Intravenous; Male; Meglumine; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pain Threshold; Phenylurea Compounds; Proglumide; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin | 2000 |
Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties.
Topics: Alanine; Analgesics; Animals; Anti-Anxiety Agents; Discrimination Learning; Discrimination, Psychological; Disulfides; Dose-Response Relationship, Drug; Indoles; Male; Meglumine; Morphine; Protease Inhibitors; Rats; Rats, Wistar | 2000 |
Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
Topics: Analgesia; Analgesics, Opioid; Animals; Diabetes Mellitus, Experimental; Drug Synergism; Hormone Antagonists; Hyperalgesia; Indoles; Injections, Intravenous; Injections, Spinal; Male; Meglumine; Morphine; Nervous System Diseases; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Touch | 2000 |
The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice.
Topics: Animals; Capsaicin; Cholecystokinin; Diabetes Mellitus, Experimental; Enzyme Activators; Hot Temperature; Hyperalgesia; Indoles; Injections, Spinal; Male; Meglumine; Mice; Mice, Inbred ICR; Nerve Fibers; Nociceptors; Pain; Protein Kinase C; Reaction Time; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spinal Cord | 2001 |
Evidence for a nucleus accumbens CCK2 receptor regulation of rat ventral pallidal GABA levels: a dual probe microdialysis study.
Topics: Animals; Bicuculline; Devazepide; gamma-Aminobutyric Acid; Hormone Antagonists; Indoles; Male; Meglumine; Microdialysis; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Tetrodotoxin | 2000 |
Role of cholecystokinin in the reduction of endomorphin-2-induced antinociception in diabetic mice.
Topics: Analgesics; Animals; Behavior, Animal; Cholecystokinin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Indoles; Injections, Intraventricular; Meglumine; Mice; Mice, Inbred ICR; Nociceptors; Oligopeptides; Pain; Pain Measurement; Sincalide | 2001 |
Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Topics: Aminopeptidases; Animals; Diabetes Mellitus, Experimental; Disulfides; Drug Synergism; Indoles; Male; Meglumine; Naloxone; Naltrexone; Neprilysin; Pain; Pain Measurement; Phenylalanine; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors; Vocalization, Animal; Weight Loss | 2001 |
CI-988 inhibits growth of small cell lung cancer cells.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Drug Screening Assays, Antitumor; Humans; Indoles; Lung Neoplasms; Meglumine; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tumor Cells, Cultured | 2001 |
The neurochemical effects of anxiolytic drugs are dependent on rearing conditions in Fawn-Hooded rats.
Topics: Animals; Anti-Anxiety Agents; Brain; Diazepam; Indoles; Male; Meglumine; Rats; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Dopamine D2; RNA, Messenger; Social Isolation; Tyrosine 3-Monooxygenase | 2003 |
Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.
Topics: Aminopeptidases; Analgesics; Animals; Disease Management; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Indoles; Male; Meglumine; Methadone; Mice; Pain; Pain Measurement; Prodrugs; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 2003 |
Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats.
Topics: Animals; Cholecystokinin; Indoles; Male; Meglumine; Pain; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; RNA, Messenger; Spinal Cord; Spinal Cord Injuries; Thorax | 2009 |
Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia.
Topics: Analysis of Variance; Animals; Anxiety; Cholecystokinin; Dominance-Subordination; Hyperalgesia; Indoles; Inflammation; Male; Meglumine; Pain Measurement; Pain Threshold; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Stress, Psychological | 2010 |
Relationship between vulnerability to reinforcing effects of morphine and activity of the endogenous cholecystokinin system in Lewis and Fischer rats.
Topics: Analysis of Variance; Animals; Cholecystokinin; Conditioning, Psychological; Enkephalins; Hormone Antagonists; Indoles; Male; Meglumine; Morphine; Narcotics; Peptide Fragments; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Cholecystokinin; Reinforcement, Psychology | 2012 |
Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety.
Topics: Adaptation, Physiological; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Brain; Brain Mapping; Brain Waves; Devazepide; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Gene Expression Regulation; Indoles; Injections, Intraventricular; Male; Maze Learning; Meglumine; Mice; Mice, Inbred C57BL; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Spectrum Analysis; Tetragastrin | 2013 |
The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway.
Topics: Aminopyridines; Amphibian Proteins; Animals; Appetite Depressants; Dopamine; Eating; Flupenthixol; Food Deprivation; Indoles; Male; Meglumine; Peptide Hormones; Photoperiod; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Corticotropin-Releasing Hormone; Signal Transduction | 2013 |
Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis.
Topics: Animals; Benzazepines; Diuresis; Dopamine Agonists; Dopamine Antagonists; Fenoldopam; Gastrins; Hormone Antagonists; Hypertension; Indoles; Kidney; Meglumine; Natriuresis; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Dopamine D1 | 2013 |
Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain Mapping; Cholecystokinin; Chronic Disease; Depressive Disorder; Indoles; Limbic System; Male; Meglumine; Mice; Mice, Inbred C57BL; Neural Pathways; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Receptor, Cholecystokinin B; Social Dominance; Stress, Psychological | 2014 |
CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; ErbB Receptors; Gastrins; Gefitinib; Hormone Antagonists; Humans; Indoles; Lung Neoplasms; Meglumine; Pyrimidines; Quinazolines | 2015 |
Contribution of CCK1 receptors to cardiovascular and respiratory effects of cholecystokinin in anesthetized rats.
Topics: Administration, Intravenous; Animals; Blood Pressure; Devazepide; Heart Rate; Indoles; Male; Meglumine; Nodose Ganglion; Rats; Rats, Wistar; Receptors, Cholecystokinin; Respiration; Respiratory Rate; Sincalide; Tidal Volume; Vagotomy | 2015 |